Search Results - "LIMONTA, P"

Refine Results
  1. 1
  2. 2

    PO-078 Role of the ER stress-autophagy axis and mitochondrial metabolism reprogramming in the apoptosis induced by δ-TOCOTRIENOL in prostate cancer by Fontana, F, Marelli, M Montagnani, Moretti, RM, Raimondi, M, Marzagalli, M, Longo, R, Crestani, M, Limonta, P

    Published in ESMO open (01-07-2018)
    “…IntroductionCastration resistant prostate cancer (CRPC) is an aggressive tumour with still limited therapeutic outcomes. Tocotrienols (TT), vitamin E…”
    Get full text
    Journal Article
  3. 3

    The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway by Limonta, P, Moretti, R M, Marelli, M M, Dondi, D, Parenti, M, Motta, M

    Published in Endocrinology (Philadelphia) (01-11-1999)
    “…Evidence has accumulated indicating that LHRH might behave as an autocrine/paracrine growth inhibitory factor in some peripheral tumors. However, LHRH…”
    Get full text
    Journal Article
  4. 4

    Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? by Montagnani Marelli, M, Moretti, R M, Januszkiewicz-Caulier, J, Motta, M, Limonta, P

    Published in Current cancer drug targets (01-05-2006)
    “…Gonadotropin-Releasing Hormone (GnRH) is the hypothalamic decapeptide which plays a key role in the control of reproductive functions. By binding to specific…”
    Get more information
    Journal Article
  5. 5

    LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action by Limonta, P, Montagnani Marelli, M, Moretti, R M

    Published in Expert opinion on investigational drugs (01-04-2001)
    “…Two classes of luteinising hormone-releasing hormone (LHRH) analogues have been developed so far to be used for oncological therapies: LHRH agonists and…”
    Get more information
    Journal Article
  6. 6

    Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression by Moretti, R M, Monagnani Marelli, M, van Groeninghen, J C, Motta, M, Limonta, P

    Published in Endocrine-related cancer (01-06-2003)
    “…Luteinizing hormone-releasing hormone (LHRH) is the key hormone in the control of reproductive functions. In recent years, it has become evident that LHRH…”
    Get full text
    Journal Article
  7. 7

    Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells by Marelli, M. Montagnani, Limonta, P., Maggi, R., Motta, M., Moretti, R.M.

    Published in The Prostate (01-11-2000)
    “…BACKGROUND The pineal hormone melatonin has been shown to exert a direct oncostatic activity on neoplastic cells, particularly from breast cancer. In the…”
    Get full text
    Journal Article
  8. 8

    Antiproliferative action of melatonin on human prostate cancer LNCaP cells by Moretti, R M, Marelli, M M, Maggi, R, Dondi, D, Motta, M, Limonta, P

    Published in Oncology reports (01-03-2000)
    “…Recent experimental evidence suggests that melatonin, the major pineal hormone, might possess oncostatic properties. The present experiments were performed to…”
    Get more information
    Journal Article
  9. 9

    Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP by Limonta, P, Dondi, D, Moretti, R M, Maggi, R, Motta, M

    “…Highly potent LH-releasing hormone (LHRH) agonists have been recently introduced in therapy for the treatment of the carcinoma of the prostate, an…”
    Get more information
    Journal Article
  10. 10

    Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells by Moretti, Roberta M, Montagnani Marelli, Marina, Motta, Marcella, Limonta, Patrizia

    Published in Oncology reports (01-09-2002)
    “…Orphan nuclear receptors constitute a subgroup of the superfamily of steroid/thyroid/retinoid receptors for which no endogenous ligand has been identified. The…”
    Get more information
    Journal Article
  11. 11

    Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP by Limonta, P, Dondi, D, Moretti, R M, Fermo, D, Garattini, E, Motta, M

    “…Recent evidence suggests that LHRH or a LHRH-like peptide might be produced by human prostatic tumor cells. To test this hypothesis, we have studied whether a…”
    Get more information
    Journal Article
  12. 12

    Effects of ovarian hormones on brain opioid binding sites in castrated female rats by Dondi, D, Limonta, P, Maggi, R, Piva, F

    Published in The American journal of physiology (01-09-1992)
    “…These experiments were performed to analyze whether treatments of ovariectomized female rats with ovarian steroid regimens able to induce either an increase…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Growth of the androgen-dependent tumor of the prostate: Role of androgens and of locally expressed growth modulatory factors by Limonta, Patrizia, Dondi, Donatella, Marelli, Marina Montagnani, Moretti, Roberta M., Negri-Cesi, Paola, Motta, Marcella

    “…The crucial role played by androgens in the growth of prostatic carcinoma is now well established. However, the mechanisms of this proliferative action are…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth by Motta, M., Dondi, D., Moretti, R.M., Marelli, M.Montagnani, Pimpinelli, F., Maggi, R., Limonta, P.

    “…Previous work carried out in the authors' laboratory has shown that LHRH agonists directly inhibit the proliferation of hormone-responsive and…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle by Piva, F, Maggi, R, Limonta, P, Motta, M, Martini, L

    Published in Endocrinology (Philadelphia) (01-08-1985)
    “…It is becoming increasingly clear that the effects exerted by opioid agonists and antagonists on the release of gonadotropins and of PRL may vary according to…”
    Get more information
    Journal Article
  17. 17

    Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat by Dondi, D, Maggi, R, Panerai, A E, Piva, F, Limonta, P

    Published in Neuroendocrinology (01-05-1991)
    “…The concentrations of beta-endorphin have been shown to change in the rat brain during pregnancy and lactation. This study has been performed in order to…”
    Get more information
    Journal Article
  18. 18

    Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion by Martini, L, Dondi, D, Limonta, P, Maggi, R, Piva, F

    Published in Journal of steroid biochemistry (01-10-1989)
    “…Several experiments have been performed in order to analyze whether physiological or experimental changes of the endocrine environment might modify the binding…”
    Get more information
    Journal Article
  19. 19

    The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans by Limonta, Patrizia, Moretti, Roberta M, Marelli, Marina Montagnani, Motta, Marcella

    Published in Frontiers in neuroendocrinology (01-12-2003)
    “…It is now well known that different forms of GnRH coexist in the same vertebrate species. In humans, two forms of GnRH have been identified so far. The first…”
    Get full text
    Journal Article
  20. 20